Gastric mucosa-associated lymphoid tissue (MALT) lymphoma: clinicopathological study and treatment outcome in 50 patients
Authors:
Open Access
- 23 December 2020
- journal article
- research article
- Published by Pan African Medical Journal in Pan African Medical Journal
- Vol. 37
Abstract
The stomach is the most frequent site of extronodal lymphoma. Mucosa-associated lymphoid tissue (MALT) lymphoma is a low-grade, B-cell neoplasm strongly associated with Helicobacter pylori (HP) infection. The presenting complaints of gastric MALT lymphoma are usually nonspecific. HP eradication is regarded as the first-line therapy in early stage disease. Management of patients who failed to achieve remission following HP eradication include chemotherapy, radiotherapy and in selected cases, surgery. The aim of the present study was to examine the clinical characteristics and treatment nutcome of natients with gastric MALT lymphoma.Keywords
This publication has 7 references indexed in Scilit:
- Clinical aspects and therapy of gastrointestinal MALT lymphomaBest Practice & Research Clinical Haematology, 2017
- Gender Aspects in Extranodal Marginal Zone B-Cell Lymphoma of the Mucosa-Associated Lymphoid Tissue: Does Sex Matter?Oncology, 2016
- Clinical characteristics and prognostic factors of primary gastric lymphomaMedicine, 2016
- Gastric MALT lymphoma: old and new insights2014
- Gela histological scoring system for post‐treatment biopsies of patients with gastric MALT lymphoma is feasible and reliable in routine practiceBritish Journal of Haematology, 2012
- Primary Low-grade and High-grade Gastric MALT-lymphoma PresentationJournal of Clinical Gastroenterology, 2010
- Primary gastric B-Cell lymphoma: Results of a prospective multicenter studyGastroenterology, 2000